Improved cardiovascular function with aminoguanidine in DOCA‐salt hypertensive rats

No abstract is available for this paper.

• Publication year

  2006

• Venue

  British Journal of Pharmacology

• Publication date

  2006-07-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1038/sj.bjp.0706801PMID 16783413PMCID PMC1751926
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• l-Arginine attenuates cardiovascular impairment in DOCA-salt hypertensive rats.

  2005cited by this paper
• The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure.

  2005cited by this paper
• Reversal of cardiac dysfunction by selective ET‐A receptor antagonism

  2005cited by this paper
• Treating diastolic heart failure with AGE crosslink breakers: thinking outside the heart failure box.

  2005cited by this paper
• Production of IL-1beta, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis.

  2005cited by this paper
• Amiloride analogues induce responses in isolated rat cardiovascular tissues by inhibition of Na+/Ca2+ exchange

  2004cited by this paper
• Advanced glycation end-product cross-link breakers. A novel approach to cardiovascular pathologies related to the aging process.

  2004cited by this paper
• Tissue angiotensin II in the regulation of inflammatory and fibrogenic components of repair in the rat heart.

  2004cited by this paper
• Cross-linking influences the impact of quantitative changes in myocardial collagen on cardiac stiffness and remodelling in hypertension in rats.

  2003influential reference
• Therapeutic potential of breakers of advanced glycation end product-protein crosslinks.

  2003influential reference
• Fibrosis, Matrix Metalloproteinases, and Inflammation in the Heart of DOCA-Salt Hypertensive Rats: Role of ETA Receptors

  2002cited by this paper
• Inhibitor for advanced glycation end products formation attenuates hypertension and oxidative damage in genetic hypertensive rats

  2002cited by this paper
• Pimagedine: a novel therapy for diabetic nephropathy

  2002cited by this paper
• Echocardiographic assessment of cardiac structure and function in rats.

  2002cited by this paper
• Increased Methylglyoxal and Oxidative Stress in Hypertensive Rat Vascular Smooth Muscle Cells

  2002cited by this paper
• Myocytes isolated from rejecting transplanted rat hearts exhibit a nitric oxide-mediated reduction in the calcium current.

  2001cited by this paper
• Aminoguanidine and Aortic Wall Mechanics, Structure, and Composition in Aged Rats

  2001cited by this paper
• Enhanced superoxide anion formation in vascular tissues from spontaneously hypertensive and desoxycorticosterone acetate-salt hypertensive rats

  2001cited by this paper
• Experimental cardiac fibrosis: differential time course of responses to mineralocorticoid-salt administration.

  2001cited by this paper
• Suppression of the development of hypertension by the inhibitor of inducible nitric oxide synthase

  2000cited by this paper
• Vascular superoxide production and vasomotor function in hypertension induced by deoxycorticosterone acetate-salt.

  2000cited by this paper
• Biological effects of aminoguanidine: An update

  1999influential reference
• Determination of inferior vena cava diameter in the angiography suite: comparison of three common methods.

  1999cited by this paper
• Interactions between NO and reactive oxygen species: pathophysiological importance in atherosclerosis, hypertension, diabetes and heart failure.

  1999cited by this paper
• Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats.

  1999cited by this paper
• Reversal of cardiac fibrosis in deoxycorticosterone acetate-salt hypertensive rats by inhibition of the renin-angiotensin system.

  1999influential reference
• Aminoguanidine has an anti-atherogenic effect in the cholesterol-fed rabbit.

  1998cited by this paper
• Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo.

  1998cited by this paper
• Aminoguanidine inhibits reactive oxygen species formation, lipid peroxidation, and oxidant-induced apoptosis.

  1998cited by this paper
• Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.

  1998cited by this paper
• Myocardial stiffness is attributed to alterations in cross-linked collagen rather than total collagen or phenotypes in spontaneously hypertensive rats.

  1997cited by this paper
• Activation of the Receptor for Advanced Glycation End Products Triggers a p21 ras -dependent Mitogen-activated Protein Kinase Pathway Regulated by Oxidant Stress*

  1997cited by this paper
• Aminoguanidine prevents the decreased myocardial compliance produced by streptozotocin-induced diabetes mellitus in rats.

  1996cited by this paper
• Chronic Dosing With Aminoguanidine and Novel Advanced Glycosylation End Product-Formation Inhibitors Ameliorates Cross-Linking of Tail Tendon Collagen in STZ-Induced Diabetic Rats

  1996cited by this paper
• Slowing of peripheral motor nerve conduction was ameliorated by aminoguanidine in streptozocin-induced diabetic rats.

  1996cited by this paper
• Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.

  1996cited by this paper
• Action potential and plateau ionic currents in moderately and severely DOCA-salt hypertrophied rat hearts.

  1996cited by this paper
• Inhibition of cataracts in moderately diabetic rats by aminoguanidine.

  1996cited by this paper
• Advanced protein glycosylation in diabetes and aging.

  1995influential reference
• Dual inhibition of nitric oxide and prostaglandin production contributes to the antiinflammatory properties of nitric oxide synthase inhibitors.

  1995cited by this paper
• Myocardial contractile dysfunction in the systemic inflammatory response syndrome: role of a cytokine-inducible nitric oxide synthase in cardiac myocytes.

  1995cited by this paper
• Cellular electrophysiology in cardiac hypertrophy and failure.

  1994cited by this paper
• Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins.

  1994cited by this paper
• Aminoguanidine selectively inhibits inducible nitric oxide synthase

  1993cited by this paper
• Cardiovascular regulatory mechanisms in advanced age.

  1993cited by this paper
• Endothelium-derived relaxing factor responses in Doca-salt hypertensive rats.

  1993cited by this paper
• Myocardial fibrosis: functional significance and regulatory factors.

  1993cited by this paper
• Mechanistic Studies of Advanced Glycosylation End Product Inhibition by Aminoguanidine

  1992cited by this paper
• Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes.

  1991cited by this paper
• Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking.

  1986influential reference
• Increased lysyl oxidase activity in blood vessels of hypertensive rats and effect of beta-aminopropionitrile on arteriosclerosis.

  1978cited by this paper

• Search for Metabolomic Markers of Hypertensive Conditions of Different Genesis: Experimental Study

  2024cites this paper
• Urine metabolic profile in rats with arterial hypertension of different genesis

  2024cites this paper
• Phillyrin improves myocardial remodeling in salt-sensitive hypertensive mice by reducing endothelin1 signaling.

  2024cites this paper
• Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents

  2023cites this paper
• The Cardioprotective Effects of Aminoguanidine on Lipopolysaccharide Induced Inflammation in Rats

  2020cites this paper
• Preventive beneficial effect of an aqueous extract of Phyllanthus amarus Schum. & Thonn. (Euphorbiaceae) on DOCA-salt-induced hypertension, cardiac hypertrophy and dysfunction, and endothelial dysfunction in rats.

  2020cites this paper
• Geranylgeraniol prevents statin-induced skeletal muscle fatigue without causing adverse effects in cardiac or vascular smooth muscle performance.

  2019cites this paper
• Activation of Liver X Receptors by GW3965 attenuated DOCA-salt hypertension-induced cardiac functional and structural changes.

  2019cites this paper
• (−)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats

  2018cites this paper
• Anti-inflammatory γ- and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats

  2017cites this paper
• Age-related changes of wall composition and collagen cross-linking in the rat carotid artery - In relation with arterial mechanics.

  2017cites this paper
• Mechanism of the anti-hypertensive property of the naturally occurring phenolic, malabaricone C in DOCA-salt rats

  2016cites this paper
• Flax lignan concentrate reverses alterations in blood pressure, left ventricular functions, lipid profile and antioxidant status in DOCA-salt induced renal hypertension in rats

  2016cites this paper
• Inducible nitric oxide synthase as a possible target in hypertension.

  2014cites this paper
• Gender differences in adenine-induced chronic kidney disease and cardiovascular complications in rats.

  2014cites this paper
• Effects of Oligomeric Grape Seed Proanthocyanidins on Heart, Aorta, Kidney in DOCA‐Salt Mice: Role of Oxidative Stress

  2013cites this paper
• GABAergic Excitation of Vasopressin Neurons: Possible Mechanism Underlying Sodium-Dependent Hypertension

  2013cites this paper
• Molecular Basis of Arterial Stiffening: Role of Glycation – A Mini-Review

  2012cites this paper
• Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.

  2012cites this paper
• Diosmin , a bio fl avonoid reverses alterations in blood pressure , nitric oxide , lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats

  2012cites this paper
• Identification and characterization of enzymes responsible for methylglyoxal overproduction in the metabolic syndrome

  2012cites this paper
• Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.

  2012cites this paper
• Veratric acid, a phenolic acid attenuates blood pressure and oxidative stress in L-NAME induced hypertensive rats.

  2011cites this paper
• Inhibition of Inflammation and Fibrosis by a Complement C5a Receptor Antagonist in DOCA-Salt Hypertensive Rats

  2011cites this paper
• Effect of an acute mechanical stimulus on aortic structure in the transverse aortic constriction mouse model

  2011cites this paper
• High-carbohydrate, High-fat Diet–induced Metabolic Syndrome and Cardiovascular Remodeling in Rats

  2011influential citation
• Cardiovascular Changes During Maturation and Ageing in Male and Female Spontaneously Hypertensive Rats

  2011cites this paper
• Resveratrol improves cardiovascular function in DOCA-salt hypertensive rats.

  2011cites this paper
• Effect of Concomitant Administration of a-tocopherol and ACEI on Cardiovascular Performance and Nucleic Acid Changes in DOCA Hypertensive Rats

  2011cites this paper
• Chronic β-adrenoceptor Antagonist Treatment Controls Cardiovascular Remodeling in Heart Failure in the Aging Spontaneously Hypertensive Rat

  2011influential citation
• The DOCA-Salt Hypertensive Rat as a Model of Cardiovascular Oxidative and Inflammatory Stress

  2010cites this paper
• Antihypertensive Efficacy of Melothria maderaspatana leaf extract on shamoperated and uninephrectomized DOCA-salt hypertensive rats

  2010cites this paper
• Antifibrotic activity of an inhibitor of histone deacetylases in DOCA‐salt hypertensive rats

  2010cites this paper
• RESEARCH PAPER Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats

  2010cites this paper
• Green tea attenuates cardiovascular remodelling and metabolic symptoms in high carbohydrate-fed rats.

  2010cites this paper
• Diastolic dysfunction and heart failure with preserved ejection fraction: rationale for RAAS antagonist/CCB combination therapy.

  2009cites this paper
• Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide‐induced type 2 diabetes

  2008cites this paper
• Attenuation of hypertension development by aminoguanidine in spontaneously hypertensive rats: role of methylglyoxal.

  2007cites this paper
• Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats.

  2007influential citation
• Novel therapeutic strategies for reducing arterial stiffness

  2006cites this paper